Euclidean Capital

Savvy Wealth gives independent financial advisors an operating platform that combines practice tools, investment support and AI-assisted client work.

Circle Pharma discovers macrocycle medicines for cancer and other serious diseases using its MXMO platform, which combines computational, structure-based design with synthetic chemistry to create cell-permeable compounds against difficult protein targets. Its lead programs are investigational and at discovery or preclinical stages.